MRK - Merck & Co., Inc.
Close
118.67
0 0%
Share volume: 4,672,208
Last Updated: Mon 23 Dec 2024 03:32:48 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.51%
PREVIOUS CLOSE
CHG
CHG%
$118.67
-19.75
0.20%
Fundamental analysis
48%
Profitability
23%
Dept financing
27%
Liquidity
65%
Performance
73%
Performance
5 Days
-0.29%
1 Month
-3.07%
3 Months
-15.20%
6 Months
-26.26%
1 Year
-8.96%
2 Year
-12.35%
Key data
Stock price
$118.67
DAY RANGE
$98.24 - $99.23
52 WEEK RANGE
$97.29 - $134.63
52 WEEK CHANGE
-$8.96
DIVIDEND
$0.77
EX-DIVIDEND DATE
06/17/2024
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Robert M. Davis
Region: US
Website: merck.com
Employees: 69,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: merck.com
Employees: 69,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Merck & Co. operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services.
Recent news